Replies to post #301470 on Amarin Corp Plc (AMRN)

[dukesking]

Tucaman, Thanks for providing us with weekly script numbers.

[Invest83838]

Generic Lovaza Still Beating Vascepa

in % gains per week

Proof that the word "Generic"

is magic to Insurance Companies and Doctors

[tm100]

T'man, thank you for the information every Friday.

[golden flyer]

it WAS NOT a holiday wee and generic L continues to outperform us

[ilovetech]

Tuca., thanks. Lovaza has a predictable sales floor of 63,000 give or take.

I'll state it a second time, I would have announced an "authorized generic" the day after the DC decision. It would have given generics REASON TO PAUSE and re-evaluate their strategy. If I'm generics, I'd have to consider, "what is the circumstantial threshold," that would stop us from entering the market? What is the risk of launching into a pool of pariahs? How can we guage the potential rewards of off-label sales to justify the endeaver, especially into a market "we single handedly prevented from developing."

Talk about biting your nose to spite your face!

ILT

[Vegas8ball]

Thank you for posting Tucaman. Regardless of GL, 92k feels good.

[Hondo1021]

Thanks Tuca. ATH on new scripts and 2nd ATH on Total scripts. Good week.

[tucaman]

Scripts for week ending 09/25/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Vascepa
TRx: 93'190 (+1.08%)
NRx: 43'794 (+1.78%)

Generic Lovaza
TRx: 64'667 (+0.13%)
NRx: 32'750 (+0.77%)